Recent Updates — EHSI

On July 31, 2026, the independent board members of Elite Health Systems Inc. approved a $525,000 subordinated note and warrant agreement with CEO Dr. Prasad Jeereddi. The unsecured note bears a 10% annual interest rate, matures on July 31, 2027, and includes a 2% prepayment penalty. Concurrently, the company issued warrants allowing Dr. Jeereddi to purchase up to 110,526 shares at $0.95 per share through July 31, 2031. The agreement permits additional investments on identical terms up to an aggregate of $1.5 million. Elite Health Systems Inc. operates in the healthcare industry.

Elite Health Systems, Inc. announced on July 10, 2026, that its Board of Directors has authorized management to pursue strategic alternatives, which may include seeking equity or debt capital, selling assets, or pursuing a merger or disposition of all assets. The company's strategic review process is no longer a timetable-driven process and no timetable has been established. Elite Health Systems, Inc. operates in the healthcare services industry, providing Medicare Advantage services through its subsidiaries.